26 Feb

Polatuzumab manuscript published on ejHaem

News, Newsletter

Congratulations to Dr Briony Shaw, Ms Eliza Chung and other investigators who utilised LaRDR data to analyse outcomes of relapsed/ refractory diffuse large B-cell lymphoma patients who received polatuzumab via compassionate access program in Australia. Visit our website for more research output.

7000th patient recrui… January 17, 2024 LaRDR supports Rare D… February 28, 2024